NCT02970422

Brief Summary

The purpose of this study is to distribute a questionnaire created for individuals living with chronic obstructive pulmonary disease (COPD) to assess their activities, participation, and healthcare and COPD-related research priorities. The data collected will be compared across diagnosed COPD stages and disease severity to determine the extent to which adults with COPD participate in the listed activities and identify their primary research and healthcare related priorities. The questionnaire was originally developed based on past research then verified by a panel of COPD and participation experts; as well as, individuals living with COPD in the form of focus groups. The questionnaire will now be administered to 200 individuals living COPD (50 in each GOLD stage) at three sites across Montreal where clinical data for each participant will be available. This phase will help establish the reliability of the questionnaire.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2016

Completed
6 months until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
21 days until next milestone

First Posted

Study publicly available on registry

November 22, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2018

Completed
2 years until next milestone

Results Posted

Study results publicly available

December 24, 2020

Completed
Last Updated

December 24, 2020

Status Verified

December 1, 2020

Enrollment Period

11 months

First QC Date

April 26, 2016

Results QC Date

August 11, 2020

Last Update Submit

December 1, 2020

Conditions

Keywords

SurveyPrioritiesActivitiesParticipation

Outcome Measures

Primary Outcomes (3)

  • Number of Participants Who Prioritized Healthcare Topics

    Twenty-four healthcare topics were selected once again from a literature and expert panel review, as well as corroborated by individuals living with COPD in five focus groups. Example healthcare topics include: relief of breathlessness; increase maximal amount of exercise individuals living with COPD can do inside and outside their homes; and prevent-lung flare-ups. Participants were asked to indicate their preference of the topics by assigning a percentage of their time, in increments of 10%, to the various healthcare topics, for a total of 100% of their time. For the 24 healthcare topics, individuals could select up to 10 topics (10% times 10 topics, for 100% of their time). The top five topics are presented as the most important topics for the participants and are indicative of areas of focus for future healthcare and research. The top five were presented in accordance to the request from the working group who developed the survey and reviewed the results.

    Baseline

  • Number of Participants Who Prioritized Research Topics

    Individuals were asked to indicate their research priorities from a list of research topics using a modified willingness-to-pay method (Kawata et al., 2014). The willingness-to-pay method allows individuals to assign preference to various topics by assigning a percentage of funds to the topic. A list of 22 research topics (e.g., to relieve breathlessness in individuals living with COPD, to increase access to lung transplantations) was created for this study through a literature review, expert consultation, and five focus groups with individuals living with COPD (n=23, 27% women). Individuals were asked to assign a percentage of funds, in increments of 10% of funding, to the 22 COPD research topics. Participants could assign anywhere between 10% of funding to 100% of funding to the topics. The top five were presented in accordance to the request from the working group who developed the survey and reviewed the results.

    Baseline

  • Number of Participants Who Were Not Satisfied With Their Participation in Daily and Social Activities

    Participants will answer questions about their participation in 26 daily activities, as well as their desire to participate in each of the 26 daily activities. This is a measure of those who indicated they wanted to increase their participation. 10 of the 26 activities and their outcome measures are listed below. Activity 1: Walking from one place to another outside of your home on a flat surface. Activity 2: Moving from one place to another using motorized transportation. Activity 3: Climbing two or more flights of stairs. Activity 4: Walking up a hill. Activity 5: Participating in regular exercise. Activity 6: Walking from one place to another in your home. Activity 7: Carrying light objects on a flat surface. Activity 8: Carrying heavy objects on a flat surface. Activity 9: Carrying-out low intensity physical activities

    Baseline

Secondary Outcomes (7)

  • Forced Expiratory Volume in 1-sec (FEV1)

    Baseline

  • FEV1/FVC

    Baseline

  • Modified Medical Research Council Questionnaire on Breathlessness

    Baseline

  • COPD Assessment Test

    Baseline

  • Godin Leisure Time Physical Activity Questionnaire

    Baseline

  • +2 more secondary outcomes

Study Arms (4)

Quartile 1 [Mild]

Other: Patient Survey

Quartile 2 [Moderate]

Other: Patient Survey

Quartile 3 [Severe]

Other: Patient Survey

Quartile 4 [Very Severe]

Other: Patient Survey

Interventions

Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.

Quartile 1 [Mild]Quartile 2 [Moderate]Quartile 3 [Severe]Quartile 4 [Very Severe]

Eligibility Criteria

Age40 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults living with chronic obstructive pulmonary disease (COPD).

You may qualify if:

  • Clinical diagnosis of COPD
  • English or French speaking
  • Patient at one of the three participating sites with medical chart

You may not qualify if:

  • No diagnosis of COPD by a healthcare professional
  • Unable to communicate in English or French
  • Unable to provide informed consent
  • No medical chart information at one of the three participating sites

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montreal Chest Institute of the McGill University Health Center (MUHC)

Montreal, Quebec, H4A 3J1, Canada

Location

Related Links

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveMotor Activity

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Results Point of Contact

Title
Emilie Michalovic, Ph.D. Candidate
Organization
McGill University

Study Officials

  • Dennis Jensen, Ph.D.

    McGill University

    PRINCIPAL INVESTIGATOR
  • Shane N Sweet, Ph.D.

    McGill University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 26, 2016

First Posted

November 22, 2016

Study Start

November 1, 2016

Primary Completion

October 1, 2017

Study Completion

December 12, 2018

Last Updated

December 24, 2020

Results First Posted

December 24, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations